Gregory Scott Duncan - Feb 26, 2024 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Stock symbol
VIRI
Transactions as of
Feb 26, 2024
Transactions value $
$0
Form type
4
Date filed
2/28/2024, 12:40 PM
Previous filing
Aug 18, 2023
Next filing
Mar 20, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +139K $0.00 139K Feb 26, 2024 Common Stock 139K $0.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest 100% on February 26, 2025, one year following the grant date.